NXI Therapeutics - Creating Tomorrow's Immunotherapies | The beginning of a new era of specificity and safety in the immunosuppressive therapy market
Location: Switzerland, Basel-City, Basel
Employees: 11-50
Founded date: 2021
Investors 1
| Date | Name | Website |
| - | Venture Ki... | venturekic... |
Mentions in press and media 5
| Date | Title | Description |
| 06.09.2024 | Kickfund invests at full throttle | Kickfund Ventures Fund I is a new investment fund dedicated to enhancing Switzerland's innovation ecosystem by supporting deep tech startups have successfully participated in the Venture Kick competition. With an initial closing of CHF 70 ... |
| 19.06.2024 | NXI Therapeutics extends pre-seed financing to CHF 3.5 million | NXI Therapeutics, a spin-off from the Biozentrum at University of Basel, is committed to creating tomorrow’s disruptive immunotherapies through modulation of coronin 1 in immune cells. Coronin 1 depletion in preclinical models allows long-... |
| 06.11.2023 | A decent representation at BIO-Europe | |
| 16.12.2022 | Newly hired executives to boost their company’s growth | |
| - | NXI Therapeutics | “NXI Therapeutics - Creating Tomorrow's Immunotherapies | The beginning of a new era of specificity and safety in the immunosuppressive therapy market” |